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Abstract
Introduction The high cost of critical care resources has
resulted in strategies to reduce the costs of ruling out low-risk
patients by developing intermediate care units (IMCs). The aim
of this study was to compare changes in total hospital costs for
intensive care patients before and after the introduction of an
IMC at the University Hospital Maastricht.
Methods The design was a comparative longitudinal study. The
setting was a university hospital with a mixed intensive care unit
(ICU), an IMC, and general wards. Changes in total hospital
costs were measured for patients who were admitted to the ICU
before and after the introduction of the IMC. The comparison of
interest was the opening of a six-bed mixed IMC.
Results The mean total hospital cost per patient increased
significantly. Before the introduction of the IMC, the total
hospital cost per patient was n12,961 (± n14,530) and
afterwards it rose to n16,513 (± n17,718). Multiple regression
analysis was used to determine to what extent patient
characteristics explained these higher hospital costs using
mortality, type of stay, diagnostic categories, length of ICU and
ward stay, and the Therapeutic Intervention Scoring System
(TISS) as predictors. More surgical patients, greater
requirements of therapeutic interventions on the ICU admission
day, and longer ICU stay in patients did explain the increase in
hospital costs, rather than the introduction of the IMC.
Conclusion After the introduction of the IMC, the higher mean
total hospital costs for patients with a high TISS score and
longer ICU stay explained the cost increase.
Introduction
The high costs of critical care have resulted in strategies for
improving intensive care utilisation and a more effective triage
[1-3]. Admitting low-risk or chronically critically ill patients to
intermediate care units (IMCs) rather than an intensive care
unit (ICU) has been proposed as an effective and efficient
strategy [4,5]. Reports on the cost-effectiveness of introduc-
ing an IMC show variable results [6-10]. Several retrospective
studies indicate reduced total costs of specialised care, which
are achieved by reducing nursing procedures and laboratory
tests. However, another trial failed to show a significant effect
on costs. Some reports show increased ICU costs during
increased bed availability. In addition, whether introducing
IMCs reduces total hospital costs is unknown. To study the
effects on ICU utilisation and costs, an IMC was opened at our
institution. The aim of the present study was to investigate
whether introducing an IMC would result in lower total hospital
and special care costs. We expected that the improved effec-
tive care would decrease these costs.
APACHE II = Acute Physiology and Chronic Health Evaluation II; ICU = intensive care unit; IMC = intermediate care unit; LOS = length of stay; TISS-
28 = Therapeutic Intervention Scoring System; TISS-28 1st day = first Therapeutic Intervention Scoring System score 24 hours after admission.Critical Care    Vol 12 No 3    Solberg et al.
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Materials and methods
Design
The study was designed as a comparative longitudinal study
that compared hospital costs as well as clinical and hospital
data of patients who were admitted to the ICU before (pre-
IMC period) and after (IMC period) the introduction of the IMC.
The total study period was 20 months: the pre-IMC period was
12 months and the IMC period was 8 months. The institutional
review board approved the study. The requirement of informed
consent was waived because the IMC was included in the
usual care and no extra variables had to be collected.
Patient population
The study population consisted of two groups of patients who
were admitted to the ICU before and after the opening of the
IMC. A total of 329 patients were randomly selected by com-
puter from the group of 795 patients during the pre-IMC
period. All patients admitted to the ICU in the IMC period were
consecutively enrolled (n = 457). Patients admitted to the ICU
who came from the IMC ('step-up' patients) were excluded
from the analysis (n = 12) to avoid other specific patient char-
acteristics from influencing the total hospital costs. The IMC
was only a step-down facility at the beginning, and only at two
months within the IMC period were step-up patients also
admitted.
Setting
The IMC was opened at University Hospital Maastricht, adja-
cent to the medical-surgical ICU. The IMC had six beds in an
open concept without isolation facilities. The general ICU was
divided in two units, one of eight beds and one of nine beds.
After the IMC had been opened, one ICU bed was closed
(reducing the total to 16). The ICU and the IMC were super-
vised and staffed by the same team of critical care physicians,
who were available in the ICU and IMC 24 hours/day, 7 days/
week. To optimise the efficiency of the IMC, bed management
was placed under the supervision of the medical ICU/IMC
team. The nursing staff for the IMC was a newly engaged team
and was supplemented with one ICU nurse per shift. The nurs-
ing team were given a special training course. The ratio of
nurses to patients in the IMC was 1:2 on the day shift and 1:3
for evenings and nights versus 1:1 in the general ICU and 1:8
in the wards.
Admission and discharge criteria for the ICU and IMC were
based upon the criteria defined by Knaus and colleagues and
Keenan and colleagues [11-14]. Identification of ICU patients
was based upon interventions that could not be performed
outside the critical care unit. These interventions were classi-
fied as 'active treatment' according to Therapeutic Intervention
Scoring System (TISS-28) variables such as mechanical ven-
tilation and left atrium monitoring. Non-active treatment varia-
bles represented interventions that could be carried out in the
IMC. Intermediate care was defined as a level of care between
intensive care and care on the general ward.
Cardiac patients were admitted to other specialised ICUs
(cardiac ICUs). These units and the recovery (24 hours)
served as overflows for general ICU patients when the general
ICU was fully occupied. ICU patients admitted to recovery
room and cardiac ICUs were excluded from the analysis. Neu-
rosurgical and cardiac-surgical patients were transferred from
the ICU to a specialised IMC integrated into the general ward.
Data collection
The data collected for each ICU patient included the following:
age, gender, length of stay (LOS) (ICU, IMC, and ward), mor-
tality (ICU and general ward), type of stay (non-surgical versus
surgical), TISS-28 score, severity of illness, and diagnostic
category. The TISS-28 has been widely applied to assess the
nursing workload and interventions in ICUs and IMCs and was
used in our study to take measurements on a daily basis via an
electronic patient-data management system [15]. The TISS-
28 is also used to categorise the level of care that patients
require [16]. The TISS-28 scores were assessed daily. The
severity of illness was measured by the Acute Physiology and
Chronic Health Evaluation II (APACHE II) scoring system on
the admission day. The severity of illness was measured by the
APACHE II. The diagnostic category was defined according to
the diagnostic classification in APACHE II (neurological, neu-
rosurgical, respiratory, gastrointestinal, cardiovascular, multi-
trauma, sepsis, renal, metabolic, and haematological) [17].
Cost analysis
The costs were analysed from the hospital point of view. The
hospital costs were calculated from admission to the ICU to
discharge from the hospital. The hospital costs for patients
from the pre-IMC period were compared with hospital costs of
patients from the IMC period. Costs were divided into costs of
ICU stay, IMC stay, and general ward stay. For each patient, all
resources used (volumes of use) were assessed on an individ-
ual basis and were based on the hospital information system.
Volumes of use consisted of, for example, ICU days, IMC days,
and general ward days and all diagnostic procedures and
medical activities in surgery, laboratory, radiology, and physio-
therapy. Surgical interventions on the day of ICU admission
were not taken into account. Unit costs were derived from the
hospital financial department. Costs per patient resulted from
multiplying the unit costs by the frequencies of resources used
for the individual patient (unit costs × volumes of use). The
cost price of an ICU day (including capacity costs) was n683
and that of a mean general ward day was n90 (range n63 to
n146). The cost price of an IMC day was calculated from the
costs of medical equipment (capacity costs), nursing staff, and
consumable costs (drugs, fluids, nutrition, and disposables)
divided by the total annual number of patient days in 2002 (n
= 646 days in 8 months). This resulted in a cost price of an
IMC day of n505. The costs of the medical staff (non)consult-
ants were not included in the cost calculation. Indirect costs
included the general hospital overhead, which was allocated
to the direct costs as an overall percentage of 35%, accordingAvailable online http://ccforum.com/content/12/3/R68
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to the Dutch guidelines for cost calculation [18]. All costs are
presented in euros (for 2002) (n1 = US $0.89).
Statistics
First, we compared the demographic and patient admission
characteristics of the pre-IMC and IMC periods by means of
the Mann-Whitney test (for continuous variables) and the chi-
square test (for categorical data). The total costs of hospital
stay were checked for normality of distribution with the Kol-
mogorov-Smirnov test. If the distribution was not normal, a
10log-based transformation was used. Next, an independent
group Student t test was applied to the cost difference of the
pre-IMC and IMC periods. Then, we performed a multiple
regression analysis using the periodic change, mortality, type
of stay, diagnostic category, and the first TISS-28 score 24
hours after admission (TISS-28 1st day) as predictors of the
total costs of hospital stay. Only effects of predictors found by
backward elimination which were statistically significant were
retained in a 'main effects' regression model. Next, cost effects
of first-order interactions between the periodic difference and
the other predictors remaining in the 'main effects' model were
introduced hierarchically into an extended regression model
by forward selection. If one of these interaction effects turned
out to be statistically significant, a subgroup regression analy-
sis was performed within the categories of the other relevant
factors involved in each interaction to inspect the modification
of the periodic difference in cost. The finally found best-fitting
model of cost, along with its explained variance, is shown. All
data analysis was done with SPSS, versions 12.0 and 15.0
(SPSS Inc., Chicago, IL, USA).
Results
Study population
Figure 1 shows the numbers of admissions to the ICU, the
IMC, and the general ward; ICU readmissions; ICU dis-
charges; ICU mean LOS; and the number of deceased
patients in the pre-IMC and IMC periods. Table 1 summarises
demographic and hospital characteristics for patients in the
same two periods.
There were statistically significant differences in the propor-
tion of surgical patients, diagnostic categories, and TISS-28
ICU stay between ICU patients in the pre-IMC and IMC peri-
ods. In the pre-IMC group, mean (± standard deviation) LOS
in the ICU and TISS-28 score of the randomly selected ICU
patients were similar to LOS in the ICU (6.2 ± 17.8 days) and
TISS-28 1st day (28.6 ± 10.4) of the total population of the
pre-IMC patients (n = 795; P = 0.2 for LOS in the ICU; P =
0.6 for TISS-28 1st day). This indicates that the random sam-
ple was representative of the total population of patients.
During the study period, ICU costs showed a tendency to
increase after the introduction of the IMC. Total mean hospital
cost per stay for ICU patients increased significantly from a
mean pre-IMC amount of n12,961 per patient to n16,513 per
patient in the IMC period (P = 0.01; n = 786). Table 2 shows
the costs specified for ICU, IMC, and general ward stays in
both the pre-IMC and IMC periods. During the ICU stay, the
cost per patient increased by n3,552, which was not signifi-
cant. Table 2 also shows the hospital costs of some relevant
factors studied. There was a significant difference in total hos-
pital costs after opening of the IMC by the group of patients
with an LOS in the ICU of more than a week (P < 0.001), in
non-readmissions to the ICU (P = 0.02), and in the group with
a TISS score on the first day in the ICU higher than the median
score (P = 0.01).
A number of variables and factors were introduced into a
forced-entry multiple regression model in an effort to explain
the cost increase. When introducing predictors as 'patient
mortality during ICU stay', 'type of stay' (surgical versus non-
surgical), 'TISS-28 1st day', LOS at the ICU, subsequent LOS
at the ward, and 'diagnostic category' (as a set of eight dummy
variables using metabolic problems as the omitted reference
category) into the regression model already containing the
'period' factor (pre-IMC versus IMC), it turned out that all of
these predictors made a statistically significant contribution to
the prediction of total hospital cost per stay for ICU patients,
except 'patient mortality' (Table 3). The higher the TISS-28
score, the higher the costs were (P < 0.001), and surgical
patients were generally more expensive than non-surgical
ones (P < 0.001). Patients having a lengthy stay at the ward
after the ICU had significantly higher total costs and, next to
this, patients having a lengthy stay at the ICU itself also had
higher total costs than at the ward (P < 0.001).
Next to this, some diagnostic categories had a statistically sig-
nificant relationship with total cost. Haematology patients and
patients with respiratory problems turned out to have higher
costs than patients with metabolic problems. In a 'main effects
model' regression analysis, next to the five statistically signifi-
cant predictors of costs ('TISS-28', 'type of stay', 'length of
stay at ICU', 'remaining length of stay at ward', and 'diagnostic
category'), the factor pre-IMC and IMC period 'period' was
always included. It turned out that the cost in total which was
statistically significant in the original t test was no longer sig-
nificant (P = 0.173). So the main effects model regression
analysis showed no significant difference in total hospital cost
between pre-IMC and IMC period controlled for the predictors
of costs. Next, effect modification of these predictors can be
tested within an extended model using the five first-order inter-
actions involving 'period' in the model. There were only two
statistically significant first-order interactions involving 'costs'
and 'period': namely, a positive one with the 'TISS-28 score' (P
= 0.009) and a negative one with the 'length of stay at the ICU'
(P = 0.002). This means that total costs for patients with rela-
tively high TISS-28 scores were significantly higher in the IMC
period compared with the pre-IMC period, but this was not the
case for the patients with scores below the median. The other
interaction effect showed that, for patients with 3 or more ICUCritical Care    Vol 12 No 3    Solberg et al.
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days, costs have significantly risen in the IMC period com-
pared with the pre-IMC period, whereas they remain the same
for patients having only 1 or 2 days in the ICU. In testing for the
remaining 10 first-order interactions not involving 'period', only
one turned out to be statistically significant. It involves the dif-
ferential effect that the 'remaining length of stay in ward' has
on the total costs given the 'admission TISS-28' score. For
both periods, a general effect strengthening of the 'TISS-28
score' on total costs is taking place for patients with a ward
stay up to 1 week compared with the patients with a ward stay
of more than 1 week. The definite, extended regression model
results are reported in Table 3.
Discussion
The ICUs generally consume a considerable proportion of
hospital resources [19,20]. Evaluation of cost and cost-effec-
tiveness is vital for assessing the impact of implementing new
strategies for improved intensive care [21,22]. This study
shows that, despite a lower cost price of an IMC day, total hos-
pital costs were not reduced after the introduction of the IMC.
By introducing the IMC, the total absolute hospital cost per
patient increased significantly from n12,961 (± n14,530) in
the pre-IMC period to n16,513 (± n17,718) in the IMC period.
This could be explained by a significantly higher LOS in the
ICU and TISS-28 1st day and not by the introduction of the
IMC itself. The patients in the IMC period were more severely i
Table 1
Patient and hospital characteristics
Pre-IMC period IMC period P value
n = 329 n = 475
Number of ICU beds 17 16
Number of IMC beds - 6
Gender, percentage of males 61.2% 59.6% 0.67a
Age, mean ± SD, years 57 ± 18.3 56 ± 18.0 0.20b
Age, 25%/median/75%, years 43/60/72 44/59/70
Surgical patients, number (percentage) 175 (53.2%) 277 (60.6%) 0.04a
Diagnostic category, number (percentage) <0.01a
Neurosurgical 41 (12.5%) 141 (30.9%)
Respiratory 88 (26.7%) 87 (19%)
Gastrointestinal 18 (5.5%) 14 (3.1%)
Cardiovascular 105 (31.9%) 134 (29.3%)
Multitrauma 36 (10.9%) 41 (9%)
Sepsis 16 (4.9%) 20 (4.4%)
Metabolic/Renal 17 (5.2%) 16 (3.6%)
Haematological 2 (0.6%) 4 (0.9%)
Length of stay in the ICU, mean ± SD, days 5.8 ± 9.2 7.0 ± 2.4 0.25b
Length of stay in the ICU, 25%/median/75%, days 1/3/6 1/2/8.5
APACHE II score, mean ± SD (number) 19.5 ± 8.2 (230) 19.9 ± 7.6 (279) 0.44b
APACHE II score, 25%/median/75% 13/19/24 14/19/25
TISS-28 score on 1st day, mean ± SD 28.9 ± 10.8 30.2 ± 11.0 0.16b
TISS-28 score on 1st day, 25%/median/75% 21/28/36 22/29/37
TISS-28 ICU stay, mean ± SD 26.9 ± 9.3 28.6 ± 9.6 0.02b
TISS-28 ICU stay, 25%/median/75% 20/26/33 22/28/35
Mortality in the ICU, number (percentage) 64 (19.5%) 115 (25.2%) 0.06a
Mortality after ICU, number (percentage) 13 (4.0%) 14 (3.1%) 0.77a
aChi-square tests. bMann-Whitney tests. APACHE II, Acute Physiology and Chronic Health Evaluation II; ICU, intensive care unit; IMC, 
intermediate care unit; SD, standard deviation; TISS-28, Therapeutic Intervention Scoring System with a median value of 28.Available online http://ccforum.com/content/12/3/R68
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Table 2
Means, standard deviations, and numbers of patients for hospital cost, also broken down for some relevant factors (n = 786)
Costs Pre-IMC period IMC period P value P value interaction
Number Mean (SD) Number Mean (SD)
Total hospital stay 329 12.961 (14.530) 457 16.513 (19.324) 0.01
ICU stay 329 10.017 (13.317) 457 13.020 (17.659) 0.07
IMC stay 0 - 143 2.612 (4.060) -
General ward stay 236 4.105 (5.924) 304 4.065 (5.095) 0.83
LOS in the ICU of <1 week 155 5.738 (5.028) 231 6.965 (5.922) 0.11
LOS in the ICU of >1 week 174 19.396 (17.010) 226 26.272 (23.058) <0.001 0.13
LOS in ward of <1 week 177 9.734 (11.125) 240 13.533 (18.476) 0.01
LOS in ward of >1 week 152 16.719 (14.045) 217 19.808 (19.743) 0.35 0.22
Readmissions to ICU 21 27.326 (18.558) 38 30.818 (5.627) 0.44
Non-readmissions to ICU 308 12.130 (13.849) 419 17.499 (847) 0.02 0.99
Surgical patients 175 14.586 (14.162) 277 18.091 (18.483) 0.06
Non-surgical patients 154 11.115 (14.766) 180 14.085 (20.365) 0.31 0.79
Deceased in hospital 77 14.444 (18.540) 129 18.292 (19.970) 0.10
Non-deceased in hospital 252 12.509 (13.073) 328 15.813 (19.049) 0.06 0.47
TISS score on 1st day < median 165 9.770 (11.125) 220 10.608 (13.140) 0.62
TISS score on 1st day > median 149 17.112 (17.138) 230 22.514 (22.450) 0.01 0.14
The P value concerns the differences between pre-IMC and IMC periods. The P value interaction tests whether the differences of studied relevant 
factors change from the pre-IMC period to the IMC period. In both tests, 10log-transformed costs were analysed. ICU, intensive care unit; IMC, 
intermediate care unit; LOS, length of stay; SD, standard deviation; TISS, Therapeutic Intervention Scoring System.
Figure 1
Pre-intermediate care unit (IMC) and IMC period flowchart of intensive care unit (ICU) patients Pre-intermediate care unit (IMC) and IMC period flowchart of intensive care unit (ICU) patients. GW, general ward; LOS, length of stay; N*, number 
of admissions; N**, number of readmissions.Critical Care    Vol 12 No 3    Solberg et al.
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ll because of greater requirements for care (as judged by the
TISS-28 score) and a longer length of ICU stay. Still, specific
groups of patients had higher costs in the IMC period com-
pared with the pre-IMC period. Patients with more than 3 days
of ICU stay had a higher cost in the IMC period compared with
the pre-IMC period.
A limited number of studies have addressed the impact of the
introducing an IMC. One study shows reduced costs without
a negative impact on outcome [7]. Another randomised study
finds no overall difference, although costs to produce a survi-
vor were reduced in the IMC [8]. Both studies, however, esti-
mated solely specialised care costs. This is the first study to
assess the effect on total hospital costs in a prospective
cohort study.
Several factors may explain the absence of reduced total hos-
pital costs despite reduced costs for intermediate care
patients. Although the IMC patients accounted for 24% of the
patients admitted for specialised care, they consume a rela-
tively small proportion of the ICU costs. The overall impact of
cost reduction by treating the low-risk patients in the IMC
instead of the ICU thus may not be relevant. In the study of
Zimmerman and colleagues [4], low-risk ICU patients con-
sumed only 8.5% of the total ICU costs, which is similar to our
results.
The calculated costs per individual TISS unit increased from
n347 to n431 during the study period. This may be due to
increases in radiographs, laboratory tests, and costs of pre-
scribed medications.
The relatively high cost price of an IMC day is related to the
low occupancy rate in the IMC in its first year and a high nurse-
to-patient ratio in the IMC. We expect the average cost to
decline with increasing occupancy rates, resulting in lower
total hospital costs per patient. For example, the total IMC cost
was n326,230 in the 8-month IMC period. The IMC has six
beds and the potential for 1,470 patient days/8 months. An
IMC occupancy rate of 85% resulted in a cost price of an IMC
day of n261. The reason for the low occupancy rate in the IMC
was the high workload of the medical and nursing teams. The
Table 3
Results of final model multiple regression analysis total cost per stay as a 'dependent' outcome variable
Number = 764
Variance explained = 0.680
Unstandardised coefficients Standardised coefficients
Predictors B Standard error Beta t Significance
Period (before → after IMC) -0.077 0.054 -0.087 -1.420 (0.156)a
TISS-28 score on 1st day 0.826 0.152 0.207 5.443 (<0.001)a
Surgical (no → yes) 0.183 0.024 0.207 7.714 <0.001
LOS in the ICU 0.025 0.001 0.688 17.307 (<0.001)a
LOS in ward 0.016 0.002 0.616 9.940 (<0.001)a
Primary organ failure (reference category is metabolic)
1. Metabolic → cardiovascular 0.066 0.076 0.070 0.871 0.384
2. Metabolic → multitrauma 0.129 0.080 0.088 1.603 0.109
3. Metabolic → gastrointestinal 0.143 0.086 0.064 1.667 0.096
4. Metabolic → haematological 0.324 0.125 0.066 2.589 0.010
5. Metabolic → renal 0.141 0.093 0.050 1.522 0.129
6. Metabolic → neurologic/neurosurgical 0.120 0.076 0.116 1.580 0.115
7. Metabolic → respiratory 0.152 0.075 0.145 2.022 0.044
8. Metabolic → sepsis 0.081 0.085 0.039 0.955 0.340
TISS × period 0.470 0.178 0.184 2.634 0.009
LOS in the ICU × period -0.005 0.002 -0.135 -3.161 0.002
LOS in ward × TISS-28 -0.022 0.005 -0.289 -4.526 <0.001
Constant 3.220 0.086 37.259 <0.001
aP values within brackets should not be taken into account as the predictors involved are also present in an interaction effect. Predictors before 
the arrow have a score of 0, those after the arrow have a score of 1. In the test, 10log-transformed costs were analysed. ICU, intensive care unit, 
IMC, intermediate care unit; LOS, length of stay, TISS-28, Therapeutic Intervention Scoring System with a median value of 28.Available online http://ccforum.com/content/12/3/R68
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same number of critical care physicians had to cover this
expansion of critical care services.
Conclusion
The cost-effectiveness of an IMC is relative to the size of the
unit and hence to the number of beds that are staffed and the
number of patients who can be treated [23]. By far the most
expensive item on the budget is nursing costs. Overall costs
per patient can be reduced considerably if the size and utilisa-
tion of an IMC are optimal. In conclusion, after the opening of
the IMC, more surgical patients, greater requirements of ther-
apeutic interventions on the ICU admission day, and longer
ICU stay in patients explained the increase in hospital costs,
rather than the introduction of the IMC itself.
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Key messages
￿  Length of intensive care unit stay was the most impor-
tant factor in the increase in total hospital cost.
￿  Difference in case mix, reflected in more surgical 
patients and a higher TISS-28 (Therapeutic Intervention 
Scoring System) score on admission day, explained the 
increase in total hospital cost after introducing an inter-
mediate care unit (IMC).
￿  Optimal size and utilisation of the IMC may reduce the 
total hospital cost per patient.